Recombinant Human CDK2AP1 Protein，His

CDK2AP1 (Cyclin-Dependent Kinase 2-Associated Protein 1) is a protein that has garnered attention in recent years due to its role in cell cycle regulation and its potential implications in cancer biology. As a regulator of cyclin-dependent kinases (CDKs), CDK2AP1 is involved in controlling the transition between different phases of the cell cycle, particularly influencing the progression through the G1 to S phase. Its expression levels and activity are often altered in various cancers, suggesting that it may function as a tumor suppressor. Studies have indicated that CDK2AP1 can inhibit cell proliferation and induce apoptosis in some cancer cell lines, making it a potential target for therapeutic strategies aimed at restoring its function in malignant cells. Additionally, the protein's involvement in cellular stress responses and its interactions with other key regulatory proteins further highlight its importance in maintaining cellular homeostasis. The exploration of CDK2AP1 as a recombinant protein has also opened new avenues for biochemical studies, allowing researchers to dissect its functional mechanisms and the pathways it regulates. Investigating CDK2AP1 and its effects on tumor biology not only enhances our understanding of cancer progression but also may lead to the development of innovative approaches for cancer treatment and prevention. As research advances, the significance of CDK2AP1 in the context of cell cycle regulation and tumorigenesis continues to be a promising area of investigation.